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Myogenic differentiationMyogenic differentiation is an essential process for the myogenesis in response to various extracellular
stimuli. p38 MAPK is a core signalling molecule in myogenic differentiation. The activation of p38 MAPK is
required for myogenic differentiation; however, themechanism for this activation remains undeﬁned. ASK1 is
a member of the MAP3K family that activates both JNK and p38 MAPK pathways in response to an array of
stresses such as oxidative stress, endoplasmic reticulum stress and calcium inﬂux. Here, we reported that
TNFα was signiﬁcantly released from H9c2 cardiac myoblast in differentiation medium. Furthermore, the
oxidant H2O2 acted as amessenger in the TNFα signalling pathway to disrupt the complex of ASK1–Trx, which
was followed by the activation of ASK1 in cardiac myogenic differentiation. Subsequently, the activated ASK1
stimulated MKK3/6–p38MAPK signalling cascade to induce speciﬁc myogenic differentiation. In addition,
exogenous TNFα added to the medium at physiological levels enhanced the ASK1–p38 MAPK signalling
pathway through the increased generation of H2O2. Interestingly, inhibition of p38 MAPK abrogated the
production of H2O2, suggesting that there might be a positive feedback loop in the myogenic–redox signalling
pathway. These results indicate that ASK1 is a new intracellular regulator of activation of the p38 MAPK in
cardiac myogenic differentiation.and Engineering Foundation
) (No. 20100028333).
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ong, Dongdaemoon-gu, Seoul
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Myogenic differentiation is a multi-step process in which
mononucleated myoblasts proliferate, then withdraw from the cell
cycle, and ﬁnally differentiate and fuse to formmultinucleatedmature
muscle ﬁbres [1]. This process can be stimulated by activation of p38
mitogen-activated protein kinase (MAPK), which is a major event
during myogenic differentiation in myoblasts and embryos [2–5]. The
activation of p38 MAPK has been shown to occur in response to a
variety of extracellular stimuli such as ultraviolet (UV) light, heat,
osmotic shock, inﬂammatory cytokines (such as TNFα and IL-1), and
growth factors (e.g., CSF-1) [6–14].
Elevated circulating TNFα is considered to be a pathological factor
that mediates such disorders such as cachexia and inﬂammatory
myopathies [15,16]. TNFα has been shown to have a physiological role
in muscle repair [17,18] and differentiation [19]. Some reports have
described an inhibitory effect of exogenous TNFα on myoblast
differentiation [20–22]; however, it is possible that TNFα has a differenteffect on myogenesis, as it has been reported that TNFα is constitutively
expressed in myoblasts [23] and its activity is upregulated in differen-
tiating myoblasts [19]. Interestingly, TNFα expression in muscle ﬁbres is
correlatedwith regenerative activity [24]. Furthermore, previous reports
have suggested that TNFα is a key regulator of myogenesis and muscle
regeneration through its activation of p38 [19,25].
In the signalling mediated by TNFα, reactive oxygen species (ROS)
act as signalling messengers [26,27]. Exposure to TNFα induces a
marked transient increases in the intracellular levels of ROS such as
superoxide (O2−) and hydrogen peroxide (H2O2) [28–31]. Indeed, these
highly reactive molecules are known to regulate many important
cellular events in response to TNFα [32]. H2O2, the proximal product of
O2− generated by superoxide dismutase (SOD), is the only ROS that can
directly function as a second messenger in a physiologically relevant
manner [33], and activate signalling pathways to stimulate cardiac
myogenic differentiation [34,35]. In addition, in vascular smoothmuscle
cells, some reports have shown that H2O2 production is important for
the expression of amore differentiated phenotype after quiescence, and
increased activity of endogenous H2O2 is associated with more
differentiated characteristics of these cells [36,37].
Apoptosis signal-regulating kinase 1 (ASK1) also known as
mitogen-activated protein kinase kinase kinase 5 (MAP3K5) is a
member of the MAP3K family and, therefore, a part of the MAPK
pathway. It activates c-Jun N-terminal kinase (JNK) and p38 MAPK in
response to stress-related stimuli, including H2O2, serum withdrawal,
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This signalling pathway triggers various biological responses, includ-
ing cell death by apoptosis in various cell types [42]. The N-terminal
portion of ASK1 interacts with the reduced form of thioredoxin (Trx).
Interaction between ASK1 and Trx is observed only under reducing
conditions, and Trx is oxidized and dissociates from ASK1 when cells
are exposed to oxidative stress such as H2O2. The H2O2-dependent
dissociation of Trx fromASK1 thus serves as amolecular switch, which
converts oxidative stress to the activation of ASK1, which can be
assessed by phosphorylation of Thr845 [43,44].
In this study, we investigate for the ﬁrst time the involvement of
ASK1 in the p38 MAPK signalling pathway during cardiac myogenic
differentiation.We also demonstrate that the involvement of H2O2 as a
messenger in the TNFα signalling pathway is mandatory for the
dissociation of the ASK1–Trx complex and the activation of ASK1, which
leads p38 MAPK-mediated cardiac myogenic differentiation.
2. Materials and methods
2.1. Materials
Dulbecco's modiﬁed Eagle's medium/F-12 (DMEM/F-12), foetal calf
serum, and horse serumwere purchased from Invitrogen (Grand Island,
NY, USA). 2′,7′-Dichlorodihydroﬂuorescein diacetate (DCF-DA), 4,5-
dihydroxy-1,3-benzenedisulfonic acid (tiron) and catalase were pur-
chased from Sigma-Aldrich Inc. (St. Louis, MO, USA). SB253580 was
purchased from Enzo Life Sciences International, Inc. (Plymouth
Meeting, PA, USA). Rat recombinant TNFα was purchased from R&D
Systems (Minneapolis, MN, USA). Antibodies speciﬁc for myosin heavy
chain (MHC), myogenin, actin, p47phox, p22phox, IκBα, p-IκBα, iNOS,
goat anti-mouse IgG-HRP, goat anti-rabbit IgG-HRP, donkey anti-goat
IgG-HRP, and A/Gproteins conjugated to agarose beadswere purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-ASK1 was
purchased from Abnova (Taipei City, Taiwan). Antibodies speciﬁc for
TNFα, pASK1 (Thr845), MKK3, pMKK3/6 (Ser189/207), and p65 (NF-
κB/Rel) were purchased from Cell Signalling Technology (Danvers, MA,
USA). p38MAPKandphosphop38 (pp38)MAPK(Thr180/Tyr182)were
purchased from Assay Designs (Ann Arbor, MI, USA).
2.2. Cell culture and transient transfection
H9c2 rat embryonic cardiac myoblasts were grown under
proliferation conditions (PM; proliferation medium) in DMEM/F12
supplemented with 10% (v/v) foetal calf serum, or under differenti-
ation conditions (DM; differentiation medium) in DM condition EM-
F12 supplemented with 2% horse serum. TNFα neutralising antibody
was included in the DM at 5 μg/ml, when indicated, to block TNFα
signalling [19]. Rat recombinant TNFα was added to the DM, as
indicated, and replenished at 12 h intervals. To inhibit p38 MAPK,
10 μM SB253580 was applied. The pcDNA3.0 constructs containing
wild type ASK1, dominant negative ASK1 (K709R), constitutively
active ASK1 (ΔN), and Trx were kindly provided by Prof. Hidenori
Ichijo of Tokyo University. Transient transfectionwas conducted using
Lipofectamine2000, according to the manufacturer's instructions
(Invitrogen, Carlsbad, CA, USA).
2.3. Subcellular fractionation
Cells were washed twice with ice-cold PBS and were collected in
150 μl of homogenization buffer (20 mM Hepes, pH 7.4, 1 mM EDTA,
22.5 mM sucrose, 1 mM sodium vanadate, 1 mM phenymethylsulfonyl
ﬂuoride [PMSF], 40 mM glycerophosphate, and 50 mM sodium ﬂuoride)
and homogenised using a Brinkmann homogenizer. The homogenates
were centrifuged at 600×g for 10 min to remove largely nuclei and
mitochondria as the sediment. The supernatant was centrifuged at
250,000×g for 90 min at 4 °C to precipitate the total membraneparticulate fraction. The resulting precipitant was resuspended in 50 μl
of homogenization buffer and centrifuged again at 15,000×g for 10 min.
The ﬁnal supernatant was used as the plasma membrane fraction.
2.4. Nuclear extract preparation
Nuclear extracts were obtained according to a previous report with
minor modiﬁcations [45]. Brieﬂy, conﬂuent cells in 10 cm diameter
dishes were detached by trypsinisation and centrifuged at 500×g at
4 °C for 5 min. The cells were suspended in PBS, centrifuged at
2000×g at 4 °C for 5 min, and once again suspended in 80 μl of buffer
(10 mM Hepes, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT,
0.2 mMPMSF, 0.5 mMEDTA, 500 μMAEBSF, 150 nM aprotinin, l μME-
64, and l μM leupeptin hemisulfate). After 10 min of incubation on ice,
the cells were lysed by adding 1.2 μl of 10% Nonidet P-40 (NP-40).
Nuclei were harvested by centrifugation at 2000×g at 4 °C for 5 min.
The nuclear pellets were suspended in 20 μl of extraction buffer
(15 mM Hepes, pH 7.9, 1.5 mM MgCl2, 200 mM KCl, 12.5% glycerol,
0.5 mM DTT, 0.2 mM PMSF, 0.4 mM EDTA, 250 μM AEBSF, 75 nM
aprotinin, 0.5 μM E-64, and 0.5 μM leupeptin hemisulfate) and
incubated on ice for 10 min. Nuclear debris was removed by
centrifugation at 22,000×g at 4 °C for 10 min.
2.5. Immunoblot analysis
Cell extracts were separated by SDS–PAGE and transferred onto a
nitrocellulose membrane. After blocking, the membrane was incu-
bated with the indicated primary antibody, followed by incubation
with a secondary antibody. Samples were detected with enhanced
chemiluminescence reagents (Santa Cruz Biotechnology). Unless
speciﬁed, actin protein was immunoblotted to standardise the
amount of sample proteins used in the immunoblot analysis.
2.6. Co-immunoprecipitation
Cells were washed twice with cold PBS, lysed in cold lysis buffer
(50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 1 mM EDTA, 1 mM PMSF, 1 mM Na3VO4, 1 mM NaF),
and lysateswere cleared by centrifugation at 14,000 rpm for 15 min. Cell
lysates (2 mg) were incubated with anti-HA and anti-Flag antibody
(5 μg) for 2 h at 4 °C. Proteins A/G conjugated to agarose beads were
added for 2 h. Beads were washed three timeswith wash buffer (50 mM
Tris–HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 1 mM PMSF, 1 mM
Na3VO4, 1 mM NaF). The beads and any bound proteins were
resuspended in SDS–PAGE sample buffer under reducing conditions
and subjected to electrophoresis.
2.7. Luciferase assay
H9c2 cells were transfectedwith 0.5 μg aliquots of the pGL2 vector or
muscle creatine kinase (MCK)-Luc construct, coupled with the internal
control plasmid, pSV-β-gal (Promega, Madison, WI, USA). The MCK-Luc
vector was generously donated by Dr. K.Y. Lee (Chungbuk National
University, Chungbuk, Korea). Cellswere harvested in 150 μl of luciferase
assay lysis buffer [46]. Luciferase and β-gal activities (data not shown)
weremeasuredwith amicroplate reader (Model 680Microplate Reader,
Bio-Rad Laboratories, Inc.Hercules, CA) using 20 μl of each cell lysate, and
luciferase activity was normalised to β-gal activity.
2.8. Flowcytometric analysis
Intracellular H2O2 was measured as previously described [47].
Brieﬂy, H2O2 was measured using DCF-DA dye (Molecular Probes,
Eugene, OR, USA). The cells were incubated in DM condition for 24 h.
Then, the cells were treatedwith 10 μMDCF-DA at 37 °C for 30 min and
resuspended in 1 ml of PBS. Fluorescence was measured on a ﬂow
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ThemeanDCF-DAﬂuorescence intensitywasmeasured at an excitation
wavelength of 488 nm and an emission wavelength of 525 nm.
2.9. Determination of TNFα concentration in culture medium
TNFα concentrations in PM and DM condition were determined
using a Rat TNFα ELISA kit (R&D Systems), according to the
manufacturer's protocol.
2.10. Statistical analysis
Results are expressed as mean±SE. Error bars represent±SE of
three independent experiments performed in triplicate. The difference
between two mean values was analysed using the Student's t-test.
Differences were considered statistically signiﬁcant when Pb0.05.
3. Results
3.1. ASK1–p38 MAPK signalling pathway is activated during cardiac
myogenic differentiation
p38 MAPK is a key regulator of myogenic differentiation and the
activity is elevated during this process [5,48,49]. Although ASK1 isFig. 1. ASK1/p38 MAPK signalling pathway is activated in cardiac myogenic differentiation. (
condition. (B) Expressions of MHC and myogenin. (C) MCK promoter activities were monito
transfectant. MCK-Luc; MCK promoter luciferase construct. (D) Activities of ASK1, MKK3/6 an
and myogenic gene expressions between the ASK1–WT transfectants and Mock transfectaninvolved in activating the p38 MAPK signalling pathway [38], the
mechanism of this activation during myogenic differentiation has not
yet been elucidated. Therefore, we investigated the activation of the
ASK1–p38 MAPK signalling cascade in the differentiation process of
H9c2, cardiac embryonic myoblasts. During the morphological trans-
formation, which took place over 96 h (Fig. 1A), the expressions of
speciﬁc myogenic markers, such as MHC and myogenin, as well as
luciferase activity of theMCKpromoter,markedly increased (Fig. 1B and
C). During theseprocesses, the signalling cascade of ASK1–MKK3/6–p38
MAPK was activated, and the expression level of Trx, which is the
intracellular binding partner of ASK1 [44], was elevated (Fig. 1D). As rat
ASK1 was not adequately detectable by any commercial antiserum, we
used transiently transfected myoblasts with an expression plasmid
encoding for hemagglutinin (HA) epitope-tagged human wild type
ASK1 (ASK1–WT). However, the ASK1–WT transfection was not
sufﬁcient to enhance the activity of p38 MAPK or the expression of
myogenic genes (Fig. 1E). These data indicate that activity of the ASK1–
p38MAPK cascade is upregulated during cardiacmuscle differentiation.
3.2. TNFα is released from cardiac myoblast during myogenic
differentiation
To verify whether differentiating myoblast releases TNFα, we
measuredTNFα concentration in the culturemediumofH9c2myoblastsA) Morphological changes were observed 96 h after incubating proliferating cells in DM
red at each time point. Cells were transiently transfected with the pGL2; empty vector
d p38, and expression of Trx in DM condition. (E) Comparison of the p38 MAPK activity
t in DM condition. In immunoblottings, actins were as used as a loading control.
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detected in PM condition,whichwas due to the presence of TNFα in the
serum added to the PM. The TNFα concentration in DM condition began
to increase as early as 1 h into differentiation, and it continued to
increase forup to48 h (Fig. 2A andB). In sharp contrastwith the changes
observed in DM condition, the TNFα concentration in the PM condition
did not change signiﬁcantly in the same period. These results show that
TNFα is spontaneously released from differentiating myoblasts.3.3. Exogenous TNFα accelerates cardiac myogenic differentiation
Considering that TNFα has opposing bimodal effects in skeletal
muscle depending on the concentrations [20,22,25], we tested whether
TNFα concentration affects the myogenic differentiation and the
activation of ASK1–p38 MAPK signalling. We treated H9c2 myoblasts
with rat recombinant TNFα at concentrations ranging from0.05 to 5 ng/
ml and observed morphological changes at 48 h after induction of
myoblast differentiation. Exogenous TNFα at low concentrations (0.05
and 0.1 ng/ml) enhanced the morphological changes and MCK
promoter activity, compared with the control at 48 h in DM condition.
High concentrations of TNFα (0.5 and 5 ng/ml) blocked the differen-
tiation completely (Fig. 3A and B). Whilst all concentrations of
exogenously added TNFα stimulated phosphorylations of ASK1,Fig. 2. TNFα release is increased in differentiating myoblasts. (A) Autocrine releases of
TNFα over the short time and (B) long time in myogenic differentiation. Differentiation
of H9c2 cardiac myoblast was induced by switching from PM to DM. At the same time,
control cells were changed into fresh PM. At each hour, the media were collected and
concentrated. TNFα concentration was determined by ELISA. Three independent
experiments were carried out. Student's t-test was performed to compare TNFα
concentration in DM condition and PM at each time point (difference: Pb0.05).MKK3/6, and p38 MAPK, the expressions of myogenin and MHC were
increased at lower concentrations and reduced at higher concentrations
(Fig. 3C). Accordingly, TNFα has bimodal effects on stimulation and
inhibition ofmyogenic differentiation depending on its concentration; it
physiologically stimulateddifferentiation at low concentrations, where-
as it pathologically impaired the differentiation at high concentrations.
3.4. TNFα generates H2O2 to activate the myogenic signalling pathway
To investigate whether TNFα contributes to H2O2 generation,
which leads to myogenic differentiation, we observed H2O2 genera-
tion in early differentiating cells with or without TNFα. The level of
H2O2 was increased up to six fold in DM condition than in PM
condition, and the level in TNFα-treated DM condition was elevated
approximately 1.5 fold over that in DM condition. Intriguingly, H2O2
production was reduced in DM supplemented with TNFα neutralising
antibody or SB203580. However, the level of H2O2 was not affected in
preimmune IgG-treated DM condition (Fig. 4A). To further investigate
the redox signalling that occurs during the cardiac myogenic
differentiation, we veriﬁed the translocation of NADPH oxidase
(Nox) to plasmamembrane and the expression level of mitochondrial
superoxide dismutase (manganese SOD, MnSOD) in DM condition,
and also observed that the exogenous TNFα accelerated the
translocation of Nox and the expression of MnSOD (Fig. 4B). These
results are in accordance with previous reports that Nox- or
mitochondria-derived H2O2 is induced by TNFα [50–52]. Additionally,
we found that the exogenous TNFα enhanced the nuclear transloca-
tion of NFκB and thus facilitated the expression of inducible nitric
oxide synthesis (iNOS) (Fig. 4B), which is a well-known downstream
modulator of NFκB that stimulates myogenic differentiation [53,54].
In accordance with the ability of TNFα to induce H2O2 production,
treatment with the TNFα neutralising antibody and SB203580 not
only inhibited the plasma membrane translocation of Nox and the
expressions of MnSOD andmyogenic markers but also diminished the
nuclear translocation of NFκB (Fig. 4B). Furthermore, we tested
whether the overexpression of a dominant negative form (K709R) of
ASK1 or the inhibition of p38 MAPK inﬂuenced the release of TNFα
from the differentiating cells. The release of TNFα from ASK1–K709R
transfectants or SB203580-treated cells was remarkably decreased
compared with ASK1–WT or Mock transfectants. These data indicate
that TNFα induced the production of H2O2, which in turn activated the
downstream signalling of p38 MAPK. Furthermore, these data
demonstrate that ASK1–p38 MAPK signalling could re-activate the
TNFα releasing during muscle differentiation.
3.5. ASK1 and Trx interact in H2O2-dependent manner during cardiac
myogenic differentiation
To examine the H2O2-dependent changes of the ASK1–Trx
complex in myogenic differentiation, we transiently cotransfected
H9c2 cells with expression plasmids encoding Flag epitope-tagged Trx
(Flag-Trx) and HA-ASK1, and then incubated the transfectants further
in DM condition with or without antioxidants such as tiron (a
superoxide scavenger) and catalase (a hydrogen peroxide catalyzing
enzyme), and the TNFα neutralising antibody. Subsequently, Flag-Trx
was immunoprecipitated, and the association of ASK1 with Trx was
assessed by immunoblotting with a HA antibody. In cells cultured
under PM condition, ASK1 and Trx existed as a complex; however, in
cells under DM condition, the complex was disrupted through
oxidation of Trx by endogenous H2O2. The complex remained
assembled in cells under DM supplemented with the TNFα neutralis-
ing antibody as well as in the antioxidants-treated cells under DM
condition (Fig. 5B, upper panel). The reverse experiments conveyed
the same results (Fig. 5B, lower panel). In accordance with the
changes in the complex, both the treatment with antioxidants and the
addition of the neutralising antibody against TNFα inhibited
Fig. 3. Exogenous TNFα exerts bimodal effects on cardiac myogenic differentiation, depending on concentration. H9c2 myoblasts were induced to differentiation in DM condition
with or without Rat recombinant TNFα added at indicated concentrations. (A) Morphological transformations were observed at 48 h and (B) MCK promoter activities were
monitored at 96 h. (C) The cells were collected at 48 h of differentiation and processed for immunoblot analysis of phosphorylated ASK1, MKK3/6, p38MAPK, myogenin, andMHC. In
immunoblots, actin was as used as a loading control.
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activation of ASK1 is accompanied by the collapse of ASK1–Trx
complex, which occurs as a result of TNFα-induced H2O2 during
myogenic differentiation (Fig. 5C). These data suggest that ASK1
dissociation from Trx is H2O2-dependent, and that activated ASK1
thus modulates the MKK3/6–p38 MAPK cascade, which is involved in
myogenic differentiation.3.6. ASK1 is required for activation of the p38 MAPK signalling cascade in
cardiac myogenic differentiation
To investigate further the importance of ASK1 in MKK3/6 and p38
MAPK cascade in myogenic differentiation, we carried out over-
expression studies with Mock and three ASK1 constructs cloned into
the vector: wild type ASK1 (WT), the dominant active form (N-
terminus deleted, ΔN) and the dominant negative form (the lysine
residue at 709 of peptide sequences point-mutated to arginine,
K709R). The transfectants did not show any activation of theMKK3/6–
p38 MAPK signalling cascade or myogenic signs in PM condition.
Therewere no differences betweenMock and ASK1–WT transfectants.
The cells overexpressing ΔN slightly accelerated the signalling
cascade and myogenic differentiation compared with ASK1–WT
transfectants in DM condition; however, the cells overexpressing
ASK1–K709R exhibited the decreased MKK3/6–p38 MAPK signalling,
and induced cell death in addition to impairment of the myogenic
differentiation (Fig. 6A and B). In accordance with the patterns of
morphological transformations and signalling activities, we obtained
the same results in the MCK luciferase activity assay (Fig. 6C). Theseresults indicate that ASK1 performs an essential function for
activating the p38 MAPK-mediated cardiac myogenic differentiation.
4. Discussion
In the present study, we ﬁrst demonstrated that ASK1 mediates
TNFα-mediated redox signalling to activate p38 MAPK in H9c2 rat
embryonic cardiac myoblast differentiation. p38 MAPK is a crucial
regulator and its activation is an essential event in myoblasts and
embryos in myogenic differentiation [49,55–57]. In a previous study,
we have also demonstrated that p38 MAPK is activated in cardiac
myoblast and positively regulates myogenic genes [58]. The ASK1–Trx
complex is a redox sensor, which functions as a molecular switch that
translates the cellular redox state into a MAPK signalling pathway
[41]. Under oxidising condition, Trx dissociates from the complex,
allowing ASK1 to become activated and promotes the activation of the
downstream MAP kinase kinase 4/7 (MKK4/7)-JNK and MKK3/6–p38
MAPK pathways. This process is crucial responding to oxidative stress
and endoplasmic reticulum stress, and for producing inﬂammatory
cytokines such as TNFα [59–64]. However, the function of ASK1 or its
response to TNFα or ROS has thus far been restricted to apoptotic
signalling in pathological conditions. Furthermore, the intracellular
signalling pathway of TNFα in myogenic differentiation has still not
been clear.
We showed that an increase in ASK1 phosphorylation induced the
morphological changes and expression of myogenic markers in
differentiating myoblasts (Fig. 1A–C), followed by the activation of
MKK3/6 and p38 MAPK (Fig. 1D). Subsequently, we showed that
differentiating myoblasts remarkably increased their release of TNFα
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regulates myogenic differentiation [19,25,65], and that physiological
levels (0.05 and 0.1 ng/ml) of exogenous TNFα enhance myogenic
differentiation [25]. On the one hand, higher concentrations (0.5 and
5 ng/ml) of exogenous TNFα blocked myogenic differentiation
(Fig. 3), which is in agreement with the previous reports that
described an inhibitory effect of exogenously added TNFα on the
myogenic differentiation [20–22]. The high concentrations of exoge-
nously added TNFα approach pathological levels [66,67]. In normal
myoblast, the level of TNFα released is estimated to be in the range of
several picograms per millilitre [68]. Thus, effect of physiological
levels of TNFα on the initiation of myogenesis cannot be concluded.
Consequently, transiently increased release of TNF-α during muscle
differentiation is essentially involved in inducing the myogenic
differentiation in physiological levels. However, a continuously
increased release of TNF-α in pathological conditions would impair
myogenic differentiation, which contribute to the muscle atrophy
associated with inﬂammatory diseases.
Previously, we have demonstrated that the level of H2O2 is increased
during myogenic differentiation [69–71]; however, there has not been
mentioned fromwhich it is originated. Therefore,wedemonstrated that
the endogenous TNFα generated H2O2 during the myogenic differen-
tiation and that exogenous TNFα enhanced the production of H2O2,
leading to increase the differentiation rate. Moreover, the neutralisation
of TNFα by its speciﬁc antibody not only decreased the generation of
H2O2 but also attenuated the differentiation of the myoblasts (Fig. 4A
and B). Additionally, inhibition of p38 activity completely abolished
myogenic fusion and expression of all myogenic markers that were
tested, and prevented the nuclear translocation of NF-κB. Thus, p38
MAPK may act as a mediator of NF-κB signalling along with ASK1 in
cardiac myogenic differentiation (Fig. 4B). These results coincide with a
previous study providing that p38 MAPK and NF-κB activities are
required for myoblast differentiation, and NF-κB is an effector of p38
MAPK [56]. Hence, the requirement of p38 MAPK and NF-κB for cell
differentiation is not exclusive to cardiac myoblasts. Interestingly,
inhibiting p38 MAPK also interfered with the membrane translocation
of p47phox and the expression of MnSOD (Fig. 4B), leading to decreased
production H2O2 (Fig. 4A), and eventually, suppressed the release of
TNFα (Fig. 4B and C). The reduction of TNFα release also occurred in
cells expressing dominant negative ASK1 (Fig. 4C). These results
suggests that there may be a positive feedback mechanism between of
TNFα, H2O2 and the ASK1–p38 MAPK cascade that contributes to
myogenic differentiation, supporting our previous study on the NADPH
oxidase activity in myogenesis [72]. Some studies have reported that
Nox andmitochondrial respiratory chain participate in H2O2 generation
induced by TNFα [50–52,73,74] and that there is a signalling cross talk
between Nox- and mitochondria-derived ROS [75,76]. Our results
showed that TNFα-induced H2O2 disrupted the ASK1–Trx complex,
allowing ASK1 to be phosphorylated (Thr845) under differentiation
conditions (Figs. 3C and5A andC). Thesedata are supported bypreviousFig. 4. Endogenous or exogenous TNFαmodulates ROS-related signalling molecules in
cardiac myogenic differentiation. Conﬂuent cells in PM condition were further
incubated in DM condition for 48 h with or without 0.1 ng/ml rat recombinant TNFα,
5 μg/ml anti-TNFα or IgG or 10 μM SB253580. Then, (A) H2O2 production with FACS
analysis 24 h after inducing differentiation. Data represent the mean±SE; ⁎Pb0.05,
compared with PM condition for DM condition or TNFα-treated DM condition.
#Pb0.05, compared with DM condition for anti-TNFα or SB253580-treated DM
condition. †Pb0.05, compared with TNFα-treated DM condition for anti-TNFα or
SB253580-treated DM condition. (B) Activities of p47phox and NF-κB, or expression of
iNOS and MnSOD were determined by immunoblotting. In immunoblottings, p22phox,
Hsp60, actin or lamin B was as used as a loading control for each subcellular fraction.
(C) Releases of TNFα in culture media. After transfections of Mocks and ASK1 dominant
negative form (K709R), TNFα concentrations were measured by ELISA technique. Data
represent the mean±SE; ⁎Pb0.05, compared with Mock transfectants in PM condition
for the cells in DM condition. #Pb0.05, compared with Mock transfectants in DM
condition for ASK1–K709R tranfectants or SB253580-treated cells in DM condition.
Fig. 5. ASK1–Trx complex is dissociated in cardiac myogenic differentiation. Conﬂuent cells in PM condition were incubated further in DM condition with or without Tiron,
Catalaseand, IgG or anti- TNFα DPI, after pcDNA3.0/HA-ASK1 and Flag-Trx were transiently transfected into the cells. (A) Morphological transformations. (B) Interaction between
ASK1 and Trxwas determined by immunoprecipitation with anti-HA or Flag, followed by Immunoblot with anti-Flag or HA (A, left). Representation of the amount of each IP input for
which ASK1 or Trx was measured with the anti-HA or Flag (A, right). (C) ASK1 phosphorylation (Thr845) was determined by immunoblot with the respective antibodies. In
immunoblottings, actins were as used as a loading control.
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exposed to H2O2 or TNFα, which stimulates the dissociation of ASK1
from Trx, and thereby activates ASK1 [41,44]. Hence, we have
demonstrated that the ASK1–Trx complex is dissociated as a result of
TNFα-induced H2O2 after initiation of myoblast differentiation, and
then, as a p38 MAPK activator, the ASK1 can be an ultimate inducer of
myogenic differentiation. Furthermore, the overexpressed ASK1–K709R
inhibited the myotube formation and the activation of MKK3/6–p38
MAPK signalling (Fig. 6), although it canbindTrx [44]. Therefore, ASK1 is
deemed as a key molecule in myogenic differentiation.
In summary, we demonstrated that the ASK1 positively regulates
p38 MAPK signalling in response to TNFα-induced H2O2 during cardiac
myogenic differentiation. Moreover, it was revealed that endogenouslygeneratedH2O2 functions as themyogenic switchmolecule that leads to
the activation of ASK1, and thus the H2O2 is a crucial redox signalling
stimulator in myogenic differentiation.
Conclusively, we ﬁrst clariﬁed that the ASK1 contributed to cardiac
muscle differentiation as a physiological process, although the cellular
function of ASK1 has thus far been limited to the pathological response.
We propose that the ASK1–p38 MAPK cascade is a newly discovered
signalling cascade that functions during cardiac myogenic differentia-
tion. We also suggested possibility that ASK1–p38 MAPK cascade could
regulate positive feedback of the TNFα in cardiac myogenic differenti-
ation. Thus, our study might contribute to an understanding of the
physiological mechanism of cardiac myogenic differentiation via the
ASK1–p38 MAPK signalling cascade.
Fig. 6. ASK1 is indispensible for the activation ofMKK3/6–p38MAPK signalling cascade in cardiac myogenic differentiation. Conﬂuent cells in PM conditionwere incubated further in DM
conditionwithorwithoutH2O2, after thepcDNA3.0, andpcDNA3.0constructs containingwild typeASK1(WT), constitutively activeASK1(ΔN)anddominant negativeASK1(K709R)were
transiently transfected into the cells. (A) Immunoblot analyses of activities ofMKK3/6 andp38MAPK.HA-ASK1 represents the expression amountof each transfection. In immunoblottings,
actin was as used as a loading control. (B) Morphological transformations. (C) MCK promoter activities were monitored at 96 h. Data represent the mean±SE; ⁎Pb0.05, compared with
Mock transfectant in PM condition for in DM condition. #Pb0.05, compared with ASK1–WT transfectant in PM condition for in DM condition. †Pb0.05, compared with ASK1-ΔN
transfectant in PM condition for in DM condition. §Pb0.05, compared with ASK1–K709R transfectant in DM condition for the other transfectants in DM condition.
1419T.G. Choi et al. / Biochimica et Biophysica Acta 1813 (2011) 1412–1421Acknowledgements
We are grateful to Dr Hidenori Ichijo (Graduate School of Pharma-
ceutical Sciences, The University of Tokyo, Japan) for providing us withthe expression vectors for wild type, constitutively active form and
dominant negative form of ASK1, respectively. This work was supported
by the Korea Science and Engineering Foundation (KOSEF) grant funded
by the Korea government (MEST) (NO. 20100028333) to S.S. Kim.
1420 T.G. Choi et al. / Biochimica et Biophysica Acta 1813 (2011) 1412–1421Appendix A. Supplementary data
Supplementary data to this article can be found online at
doi:10.1016/j.bbamcr.2011.04.001.
References
[1] A. Blais, M. Tsikitis, D. Acosta-Alvear, R. Sharan, Y. Kluger, B.D. Dynlacht, An initial
blueprint for myogenic differentiation, Genes Dev. 19 (2005) 553–569.
[2] C. Cabane, W. Englaro, K. Yeow, M. Ragno, B. Derijard, Regulation of C2C12
myogenic terminal differentiation by MKK3/p38alpha pathway, Am. J. Physiol.
Cell Physiol. 284 (2003) C658–C666.
[3] L. de Angelis, J. Zhao, J.J. Andreucci, E.N. Olson, G. Cossu, J.C. McDermott,
Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2
signaling pathway, Dev. Biol. 283 (2005) 171–179.
[4] P.L. Puri, Z. Wu, P. Zhang, L.D. Wood, K.S. Bhakta, J. Han, J.R. Feramisco, M. Karin, J.
Y. Wang, Induction of terminal differentiation by constitutive activation of p38
MAP kinase in human rhabdomyosarcoma cells, Genes Dev. 14 (2000) 574–584.
[5] Z. Wu, P.J. Woodring, K.S. Bhakta, K. Tamura, F. Wen, J.R. Feramisco, M. Karin, J.Y.
Wang, P.L. Puri, p38 and extracellular signal-regulated kinases regulate the
myogenic program at multiple steps, Mol. Cell. Biol. 20 (2000) 3951–3964.
[6] L. Shapiro, A.J. Puren, H.A. Barton, D. Novick, R.L. Peskind, R. Shenkar, Y. Gu, M.S.
Su, C.A. Dinarello, Interleukin 18 stimulates HIV type 1 in monocytic cells, Proc.
Natl. Acad. Sci. U. S. A. 95 (1998) 12550–12555.
[7] A. Pietersma, B.C. Tilly, M. Gaestel, N. de Jong, J.C. Lee, J.F. Koster, W. Sluiter, p38
mitogen activated protein kinase regulates endothelial VCAM-1 expression at the
post-transcriptional level, Biochem. Biophys. Res. Commun. 230 (1997) 44–48.
[8] J. Han, J.D. Lee, L. Bibbs, R.J. Ulevitch, A MAP kinase targeted by endotoxin and
hyperosmolarity in mammalian cells, Science 265 (1994) 808–811.
[9] J. Rouse, P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T.
Hunt, A.R. Nebreda, A novel kinase cascade triggered by stress and heat shock that
stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock
proteins, Cell 78 (1994) 1027–1037.
[10] N.W. Freshney, L. Rawlinson, F. Guesdon, E. Jones, S. Cowley, J. Hsuan, J. Saklatvala,
Interleukin-1 activates a novel protein kinase cascade that results in the
phosphorylation of Hsp27, Cell 78 (1994) 1039–1049.
[11] J. Raingeaud, S. Gupta, J.S. Rogers, M. Dickens, J. Han, R.J. Ulevitch, R.J. Davis, Pro-
inﬂammatory cytokines and environmental stress cause p38 mitogen-activated
protein kinase activation by dual phosphorylation on tyrosine and threonine,
J. Biol. Chem. 270 (1995) 7420–7426.
[12] J.C. Lee, J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, D. Green, D. McNulty,
M.J. Blumenthal, J.R. Heys, S.W. Landvatter, et al., A protein kinase involved in the
regulation of inﬂammatory cytokine biosynthesis, Nature 372 (1994) 739–746.
[13] T. Shalom-Barak, J. Quach, M. Lotz, Interleukin-17-induced gene expression in
articular chondrocytes is associated with activation of mitogen-activated protein
kinases and NF-kappaB, J. Biol. Chem. 273 (1998) 27467–27473.
[14] I.N. Foltz, J.C. Lee, P.R. Young, J.W. Schrader, Hemopoietic growth factors with the
exception of interleukin-4 activate the p38 mitogen-activated protein kinase
pathway, J. Biol. Chem. 272 (1997) 3296–3301.
[15] I.E. Lundberg, M. Dastmalchi, Possible pathogenic mechanisms in inﬂammatory
myopathies, Rheum. Dis. Clin. North Am. 28 (2002) 799–822.
[16] M.B. Reid, Y.P. Li, Cytokines and oxidative signalling in skeletal muscle, Acta
Physiol. Scand. 171 (2001) 225–232.
[17] S.E. Chen, E. Gerken, Y. Zhang, M. Zhan, R.K. Mohan, A.S. Li, M.B. Reid, Y.P. Li, Role
of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle, Am. J.
Physiol. Cell Physiol. 289 (2005) C1179–C1187.
[18] G.L. Warren, T. Hulderman, N. Jensen, M. McKinstry, M. Mishra, M.I. Luster, P.P.
Simeonova, Physiological role of tumor necrosis factor alpha in traumatic muscle
injury, FASEB J. 16 (2002) 1630–1632.
[19] Y.P. Li, R.J. Schwartz, TNF-alpha regulates early differentiation of C2C12 myoblasts
in an autocrine fashion, FASEB J. 15 (2001) 1413–1415.
[20] D.C. Guttridge, M.W. Mayo, L.V. Madrid, C.Y. Wang, A.S. Baldwin Jr., NF-kappaB-
induced loss of MyoDmessenger RNA: possible role inmuscle decay and cachexia,
Science 289 (2000) 2363–2366.
[21] R.C. Langen, A.M. Schols, M.C. Kelders, J.L. Van Der Velden, E.F. Wouters, Y.M.
Janssen-Heininger, Tumor necrosis factor-alpha inhibits myogenesis through
redox-dependent and -independent pathways, Am. J. Physiol. Cell Physiol. 283
(2002) C714–C721.
[22] R.C. Langen, A.M. Schols, M.C. Kelders, E.F. Wouters, Y.M. Janssen-Heininger,
Inﬂammatory cytokines inhibit myogenic differentiation through activation of
nuclear factor-kappaB, FASEB J. 15 (2001) 1169–1180.
[23] M. Saghizadeh, J.M. Ong, W.T. Garvey, R.R. Henry, P.A. Kern, The expression of TNF
alpha by human muscle. Relationship to insulin resistance, J. Clin. Invest. 97
(1996) 1111–1116.
[24] S. Kuru, A. Inukai, T. Kato, Y. Liang, S. Kimura, G. Sobue, Expression of tumor
necrosis factor-alpha in regenerating muscle ﬁbers in inﬂammatory and non-
inﬂammatory myopathies, Acta Neuropathol. 105 (2003) 217–224.
[25] S.E. Chen, B. Jin, Y.P. Li, TNF-alpha regulates myogenesis and muscle regeneration
by activating p38 MAPK, Am. J. Physiol. Cell Physiol. 292 (2007) C1660–C1671.
[26] Y.Y. Lo, T.F. Cruz, Involvement of reactive oxygen species in cytokine and growth
factor induction of c-fos expression in chondrocytes, J. Biol. Chem. 270 (1995)
11727–11730.
[27] Y.Y. Lo, J.M. Wong, T.F. Cruz, Reactive oxygen species mediate cytokine activation
of c-Jun NH2-terminal kinases, J. Biol. Chem. 271 (1996) 15703–15707.[28] H.H. Radeke, B. Meier, N. Topley, J. Floge, G.G. Habermehl, K. Resch, Interleukin 1-
alpha and tumor necrosis factor-alpha induce oxygen radical production in
mesangial cells, Kidney Int. 37 (1990) 767–775.
[29] M. Sundaresan, Z.X. Yu, V.J. Ferrans, D.J. Sulciner, J.S. Gutkind, K. Irani, P.J.
Goldschmidt-Clermont, T. Finkel, Regulation of reactive-oxygen-species genera-
tion in ﬁbroblasts by Rac1, Biochem. J. 318 (Pt 2) (1996) 379–382.
[30] J.M. Hansen, H. Zhang, D.P. Jones, Mitochondrial thioredoxin-2 has a key role in
determining tumor necrosis factor-alpha-induced reactive oxygen species
generation, NF-kappaB activation, and apoptosis, Toxicol. Sci. 91 (2006) 643–650.
[31] X. Gao, H. Zhang, S. Belmadani, J. Wu, X. Xu, H. Elford, B.J. Potter, C. Zhang, Role of
TNF-alpha-induced reactive oxygen species in endothelial dysfunction during
reperfusion injury, Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H2242–H2249.
[32] D.J. Sulciner, K. Irani, Z.X. Yu, V.J. Ferrans, P. Goldschmidt-Clermont, T. Finkel, rac1
regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-
kappaB activation, Mol. Cell. Biol. 16 (1996) 7115–7121.
[33] H.J. Forman, J.M. Fukuto, M. Torres, Redox signaling: thiol chemistry deﬁneswhich
reactive oxygen and nitrogen species can act as secondmessengers, Am. J. Physiol.
Cell Physiol. 287 (2004) C246–C256.
[34] J. Li, M. Stouffs, L. Serrander, B. Banﬁ, E. Bettiol, Y. Charnay, K. Steger, K.H. Krause,
M.E. Jaconi, The NADPH oxidase NOX4 drives cardiac differentiation: role in
regulating cardiac transcription factors and MAP kinase activation, Mol. Biol. Cell
17 (2006) 3978–3988.
[35] H. Sauer, G. Rahimi, J. Hescheler, M. Wartenberg, Role of reactive oxygen species
and phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic
stem cells, FEBS Lett. 476 (2000) 218–223.
[36] B. Su, S. Mitra, H. Gregg, S. Flavahan, M.A. Chotani, K.R. Clark, P.J. Goldschmidt-
Clermont, N.A. Flavahan, Redox regulation of vascular smooth muscle cell
differentiation, Circ. Res. 89 (2001) 39–46.
[37] Q.Z. Xiao, Z.L. Luo, A.E. Pepe, A. Margariti, L.F. Zeng, Q.B. Xu, Embryonic stem cell
differentiation into smooth muscle cells is mediated by Nox4-produced H2O2,
Am. J. Physiol. Cell Physiol. 296 (2009) C711–C723.
[38] H. Ichijo, E. Nishida, K. Irie, P. ten Dijke, M. Saitoh, T. Moriguchi, M. Takagi, K.
Matsumoto, K. Miyazono, Y. Gotoh, Induction of apoptosis by ASK1, a mammalian
MAPKKK that activates SAPK/JNK and p38 signaling pathways, Science 275 (1997)
90–94.
[39] H.Y. Chang, H. Nishitoh, X. Yang, H. Ichijo, D. Baltimore, Activation of apoptosis
signal-regulating kinase 1 (ASK1) by the adapter protein Daxx, Science 281
(1998) 1860–1863.
[40] H. Nishitoh, M. Saitoh, Y. Mochida, K. Takeda, H. Nakano, M. Rothe, K. Miyazono, H.
Ichijo, ASK1 is essential for JNK/SAPK activation by TRAF2, Mol. Cell 2 (1998)
389–395.
[41] H. Liu, H. Nishitoh, H. Ichijo, J.M. Kyriakis, Activation of apoptosis signal-regulating
kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior
dissociation of the ASK1 inhibitor thioredoxin, Mol. Cell. Biol. 20 (2000) 2198–2208.
[42] K. Takeda, A. Matsuzawa, H. Nishitoh, H. Ichijo, Roles of MAPKKK ASK1 in stress-
induced cell death, Cell Struct. Funct. 28 (2003) 23–29.
[43] H. Liu, H. Zhang, K.E. Iles, A. Rinna, G. Merrill, J. Yodoi, M. Torres, H.J. Forman, The
ADP-stimulated NADPH oxidase activates the ASK-1/MKK4/JNK pathway in
alveolar macrophages, Free Radic. Res. 40 (2006) 865–874.
[44] M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K.
Miyazono, H. Ichijo, Mammalian thioredoxin is a direct inhibitor of apoptosis
signal-regulating kinase (ASK) 1, EMBO J. 17 (1998) 2596–2606.
[45] M. Shibanuma, T. Kuroki, K. Nose, Stimulation by hydrogen peroxide of DNA
synthesis, competence family gene expression and phosphorylation of a speciﬁc
protein in quiescent Balb/3T3 cells, Oncogene 5 (1990) 1025–1032.
[46] K.B. Beckman, B.N. Ames, The free radical theory of aging matures, Physiol. Rev. 78
(1998) 547–581.
[47] K.J. Choi, Y.J. Piao, M.J. Lim, J.H. Kim, J. Ha, W. Choe, S.S. Kim, Overexpressed
cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced
cell death, Cancer Res. 67 (2007) 3654–3662.
[48] A. Cuenda, P. Cohen, Stress-activated protein kinase-2/p38 and a rapamycin-
sensitive pathway are required for C2C12 myogenesis, J. Biol. Chem. 274 (1999)
4341–4346.
[49] A. Zetser, E. Gredinger, E. Bengal, p38 mitogen-activated protein kinase pathway
promotes skeletal muscle differentiation. Participation of the Mef2c transcription
factor, J. Biol. Chem. 274 (1999) 5193–5200.
[50] K. Imoto, D. Kukidome, T. Nishikawa, T. Matsuhisa, K. Sonoda, K. Fujisawa, M.
Yano, H. Motoshima, T. Taguchi, K. Tsuruzoe, T. Matsumura, H. Ichijo, E. Araki,
Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating
kinase 1 on insulin signaling, Diabetes 55 (2006) 1197–1204.
[51] R.S. Frey, A. Rahman, J.C. Kefer, R.D. Minshall, A.B. Malik, PKCzeta regulates TNF-
alpha-induced activation of NADPH oxidase in endothelial cells, Circ. Res. 90 (2002)
1012–1019.
[52] S. Basuroy, S. Bhattacharya, C.W. Lefﬂer, H. Parfenova, Nox4 NADPH oxidase
mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular
endothelial cells, Am. J. Physiol. Cell Physiol. 296 (2009) C422–C432.
[53] K.H. Lee, D.G. Kim, N.Y. Shin, W.K. Song, H. Kwon, C.H. Chung, M.S. Kang, NF-
kappaB-dependent expression of nitric oxide synthase is required for membrane
fusion of chick embryonic myoblasts, Biochem. J. 324 (Pt 1) (1997) 237–242.
[54] P. Kaliman, J. Canicio, X. Testar, M. Palacin, A. Zorzano, Insulin-like growth factor-II,
phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide
synthase deﬁne a common myogenic signaling pathway, J. Biol. Chem. 274 (1999)
17437–17444.
[55] A. Keren, E. Bengal, D. Frank, p38 MAP kinase regulates the expression of XMyf5
and affects distinct myogenic programs during Xenopus development, Dev. Biol.
288 (2005) 73–86.
1421T.G. Choi et al. / Biochimica et Biophysica Acta 1813 (2011) 1412–1421[56] B. Baeza-Raja, P. Munoz-Canoves, p38 MAPK-induced nuclear factor-kappaB
activity is required for skeletal muscle differentiation: role of interleukin-6, Mol.
Biol. Cell 15 (2004) 2013–2026.
[57] N.R. Bhat, D.L. Feinstein, Q. Shen, A.N. Bhat, p38 MAPK-mediated transcriptional
activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors,
nuclear factor kappa B, cAMP response element-binding protein, CCAAT/
enhancer-binding protein-beta, and activating transcription factor-2, J. Biol.
Chem. 277 (2002) 29584–29592.
[58] Y.K. Chun, J. Kim, S. Kwon, S.H. Choi, F. Hong, K. Moon, J.M. Kim, S.L. Choi, B.S. Kim,
J. Ha, S.S. Kim, Phosphatidylinositol 3-kinase stimulates muscle differentiation by
activating p38 mitogen-activated protein kinase, Biochem. Biophys. Res. Com-
mun. 276 (2000) 502–507.
[59] A. Matsuzawa, K. Saegusa, T. Noguchi, C. Sadamitsu, H. Nishitoh, S. Nagai, S.
Koyasu, K. Matsumoto, K. Takeda, H. Ichijo, ROS-dependent activation of the
TRAF6–ASK1–p38 pathway is selectively required for TLR4-mediated innate
immunity, Nat. Immunol. 6 (2005) 587–592.
[60] R.J. Davis, Signal transduction by the JNK group of MAP kinases, Cell 103 (2000)
239–252.
[61] K. Takeda, A. Matsuzawa, H. Nishitoh, K. Tobiume, S. Kishida, J. Ninomiya-Tsuji, K.
Matsumoto, H. Ichijo, Involvement of ASK1 in Ca2+−induced p38 MAP kinase
activation, EMBO Rep. 5 (2004) 161–166.
[62] K. Tobiume, A. Matsuzawa, T. Takahashi, H. Nishitoh, K. Morita, K. Takeda, O.
Minowa, K. Miyazono, T. Noda, H. Ichijo, ASK1 is required for sustained activations
of JNK/p38 MAP kinases and apoptosis, EMBO Rep. 2 (2001) 222–228.
[63] Y. Liu, G. Yin, J. Surapisitchat, B.C. Berk, W.Min, Laminar ﬂow inhibits TNF-induced
ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3,
J. Clin. Invest. 107 (2001) 917–923.
[64] R. Zhang, X. He, W. Liu, M. Lu, J.T. Hsieh, W. Min, AIP1 mediates TNF-alpha-
induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-
3-3, J. Clin. Invest. 111 (2003) 1933–1943.
[65] M. Zhan, B. Jin, S.E. Chen, J.M. Reecy, Y.P. Li, TACE release of TNF-alpha mediates
mechanotransduction-induced activation of p38MAPK andmyogenesis, J. Cell Sci.
120 (2007) 692–701.
[66] J. Nakashima, M. Tachibana, M. Ueno, S. Baba, H. Tazaki, Tumor necrosis factor and
coagulopathy in patients with prostate cancer, Cancer Res. 55 (1995) 4881–4885.[67] G. Vreugdenhil, B. Lowenberg, H.G. Van Eijk, A.J. Swaak, Tumor necrosis factor
alpha is associated with disease activity and the degree of anemia in patients with
rheumatoid arthritis, Eur. J. Clin. Invest. 22 (1992) 488–493.
[68] M. Federici, M.L. Hribal, R. Menghini, H. Kanno, V. Marchetti, O. Porzio, S.W.
Sunnarborg, S. Rizza, M. Serino, V. Cunsolo, D. Lauro, A. Mauriello, D.S. Smookler, P.
Sbraccia, G. Sesti, D.C. Lee, R. Khokha, D. Accili, R. Lauro, Timp3 deﬁciency in
insulin receptor-haploinsufﬁcient mice promotes diabetes and vascular inﬂam-
mation via increased TNF-alpha, J. Clin. Invest. 115 (2005) 3494–3505.
[69] J. Lee, K.J. Choi,M.J. Lim, F.Hong, T.G. Choi, E. Tak, S. Lee,Y.J. Kim, S.G. Chang, J.M.Cho, J.
Ha, S.S. Kim, Proto-oncogenic H-Ras, K-Ras, and N-Ras are involved in muscle
differentiation via phosphatidylinositol 3-kinase, Cell Res. 20 (2010) 919–934.
[70] M.J. Lim, Y.H. Seo, K.J. Choi, C.H. Cho, B.S. Kim, Y.H. Kim, J. Lee, H. Lee, C.Y. Jung, J.
Ha, I. Kang, S.S. Kim, Suppression of c-Src activity stimulates muscle differenti-
ation via p38 MAPK activation, Arch. Biochem. Biophys. 465 (2007) 197–208.
[71] J. Lee, F. Hong, S. Kwon, S.S. Kim, D.O. Kim, H.S. Kang, S.J. Lee, J. Ha, Activation of
p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during
muscle differentiation, Biochem. Biophys. Res. Commun. 298 (2002) 765–771.
[72] Y.J. Piao, Y.H. Seo, F. Hong, J.H. Kim, Y.J. Kim, M.H. Kang, B.S. Kim, S.A. Jo, I. Jo, D.M.
Jue, I. Kang, J. Ha, S.S. Kim, Nox 2 stimulates muscle differentiation via NF-kappaB/
iNOS pathway, Free Radic. Biol. Med. 38 (2005) 989–1001.
[73] V. Goossens, J. Grooten, K. De Vos, W. Fiers, Direct evidence for tumor necrosis
factor-induced mitochondrial reactive oxygen intermediates and their involve-
ment in cytotoxicity, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8115–8119.
[74] C. Garcia-Ruiz, A. Colell, M. Mari, A. Morales, J.C. Fernandez-Checa, Direct effect of
ceramide on the mitochondrial electron transport chain leads to generation of
reactive oxygen species. Role of mitochondrial glutathione, J. Biol. Chem. 272
(1997) 11369–11377.
[75] P. Wenzel, H. Mollnau, M. Oelze, E. Schulz, J.M. Wickramanayake, J. Muller, S.
Schuhmacher, M. Hortmann, S. Baldus, T. Gori, R.P. Brandes, T. Munzel, A. Daiber,
First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived
reactive oxygen species in nitroglycerin-triggered vascular dysfunction, Antioxid.
Redox Signal. 10 (2008) 1435–1447.
[76] S.B. Lee, I.H. Bae, Y.S. Bae, H.D. Um, Link between mitochondria and NADPH
oxidase 1 isozyme for the sustained production of reactive oxygen species and cell
death, J. Biol. Chem. 281 (2006) 36228–36235.
